Skip to main navigation Skip to search Skip to main content

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

  • Toby A. Eyre
  • , Ruth Clifford
  • , Adrian Bloor
  • , Lucy Boyle
  • , Corran Roberts
  • , Maite Cabes
  • , Graham P. Collins
  • , Stephen Devereux
  • , George Follows
  • , Christopher P. Fox
  • , John Gribben
  • , Peter Hillmen
  • , Chris S. Hatton
  • , Tim J. Littlewood
  • , Helen McCarthy
  • , Jim Murray
  • , Andrew R. Pettitt
  • , Elizabeth Soilleux
  • , Basile Stamatopoulos
  • , Sharon B. Love
  • Andrew Wotherspoon, Anna Schuh
  • Oxford University Hospitals NHS Foundation Trust
  • John Radcliffe Hospital
  • The Christie NHS Foundation Trust
  • University of Oxford
  • King's College London
  • Cambridge University Hospitals NHS Foundation Trust
  • Nottingham University Hospitals NHS Trust
  • Queen Mary University of London
  • University of Leeds
  • University Hospitals Dorset NHS Foundation Trust
  • University Hospitals Birmingham NHS Foundation Trust
  • Liverpool University Hospitals NHS Foundation Trust
  • University of Liverpool
  • Université libre de Bruxelles
  • Royal Marsden NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology